Autoantibodies to RuvBL1 and RuvBL2: A novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement

Arthritis Care and Research

Volumn 66, Issue 4, 2014, Pages 575-584

  Kaji, Kenzou ^a   Fertig, Noreen ^b   Medsger Jr , Thomas A ^b   Satoh, Takashi ^c   Hoshino, Kana ^c   Hamaguchi, Yasuhito ^a   Hasegawa, Minoru ^a   Lucas, Mary ^b   Schnure, Andrew ^b   Ogawa, Fumihide ^d   Sato, Shinichi ^e   Takehara, Kazuhiko ^a   Fujimoto, Manabu ^a   Kuwana, Masataka ^c  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NAGASAKI UNIVERSITY   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; RUVBL1 ANTIBODY; RUVBL2 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL EVALUATION; COHORT ANALYSIS; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INTERSTITIAL LUNG DISEASE; LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY MASS SPECTROMETRY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MIDDLE AGED; MYOSITIS; RNA ANALYSIS; SKELETAL MUSCLE; SKINFOLD; SYSTEMIC SCLEROSIS;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; BIOLOGICAL MARKERS; CARRIER PROTEINS; CASE-CONTROL STUDIES; COHORT STUDIES; DNA HELICASES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOSITIS; SCLERODERMA, DIFFUSE; YOUNG ADULT;

EID: 84896922114     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22163     Document Type: Article

References (28)

1. Steen VD,. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2005; 35: 35-42.
2. Villalta D, Imbastaro T, Di Giovanni S, Lauriti C, Gabini M, Turi MC, et al. Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis. Autoimmun Rev 2012; 12: 114-20.
3. Hamaguchi Y, Hasegawa M, Fujimoto M, Matsushita T, Komura K, Kaji K, et al. The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis. Br J Dermatol 2008; 158: 487-95.
4. Satoh T, Ishikawa O, Ihn H, Endo H, Kawaguchi Y, Sasaki T, et al. Clinical usefulness of anti-RNA polymerase III antibody measurement by enzyme-linked immunosorbent assay. Rheumatology (Oxford) 2009; 48: 1570-4.
5. Fertig N, Domsic RT, Rodriguez-Reyna T, Kuwana M, Lucas M, Medsger TA Jr, et al. Anti-U11/U12 RNP antibodies in systemic sclerosis: a new serologic marker associated with pulmonary fibrosis. Arthritis Rheum 2009; 61: 958-65.
6. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
7. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
8. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
9. Bohan A, Peter JB,. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 344-7.
10. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-38.
11. Koschik RW II, Fertig N, Lucus MR, Domsic RT, Medsger TA Jr,. Anti-PM-Scl antibody in patients with systemic sclerosis. Clin Exp Rheumatol 2012; 30 Suppl: S12-6.
12. Medsger TA Jr,. Systemic sclerosis (scleroderma): clinical aspects. In:, Koopman WJ, editor. Arthritis and allied conditions. 13th ed. Philadelphia: Williams & Wilkins; 1997. p. 1433-64.
13. Kuwana M, Kaburaki J, Okano Y, Tojo T, Homma M,. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum 1994; 37: 75-83.
14. Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 2005; 52: 1571-6.
15. Suzuki S, Satoh T, Yasuoka H, Hamaguchi Y, Tanaka K, Kawakami Y, et al. Novel autoantibodies to a voltage-gated potassium channel Kv1.4 in a severe form of myasthenia gravis. J Neuroimmunol 2005; 170: 141-9.
16. Ishida T, Ichihara M, Wang X, Yamamoto K, Kimura J, Majima E, et al. Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes. J Control Release 2006; 112: 15-25.
17. Fujimoto M, Hamaguchi Y, Kaji K, Matsushita T, Ichimura Y, Kodera M, et al. Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins. Arthritis Rheum 2012; 64: 513-22.
18. Kuwana M, Kimura K, Kawakami Y,. Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: application to enzyme-linked immunosorbent assay. Arthritis Rheum 2002; 46: 2742-7.
19. Jha S, Dutta A,. RVB1/RVB2: running rings around molecular biology. Mol Cell 2009; 34: 521-33.
20. Matias PM, Gorynia S, Donner P, Carrondo MA,. Crystal structure of the human AAA+ protein RuvBL1. J Biol Chem 2006; 281: 38918-29.
21. Makino Y, Mimori T, Koike C, Kanemaki M, Kurokawa Y, Inoue S, et al. TIP49, homologous to the bacterial DNA helicase RuvB, acts as an autoantigen in human. Biochem Biophys Res Commun 1998; 245: 819-23.
22. Kuwana M, Okano Y, Kaburaki J, Tojo T, Medsger TA Jr,. Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies. Arthritis Rheum 1994; 37: 902-6.
23. Kuwana M, Kaburaki J, Medsger TA Jr, Wright TM,. An immunodominant epitope on DNA topoisomerase I is conformational in nature: heterogeneity in its recognition by systemic sclerosis sera. Arthritis Rheum 1999; 42: 1179-88.
24. Kuwana M, Okano Y, Kaburaki J, Medsger TA Jr, Wright TM,. Autoantibodies to RNA polymerases recognize multiple subunits and demonstrate cross-reactivity with RNA polymerase complexes. Arthritis Rheum 1999; 42: 275-84.
25. Kuwana M, Kimura K, Hirakata M, Kawakami Y, Ikeda Y,. Differences in autoantibody response to Th/To between systemic sclerosis and other autoimmune diseases. Ann Rheum Dis 2002; 61: 842-6.
26. Gelpi C, Alguero A, Angeles Martinez M, Vidal S, Juarez C, Rodriguez-Sanchez JL,. Identification of protein components reactive with anti-PM/Scl autoantibodies. Clin Exp Immunol 1990; 81: 59-64.
27. Walker JR, Corpina RA, Goldberg J,. Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair. Nature 2001; 412: 607-14.
28. Schilders G, van Dijk E, Raijmakers R, Pruijn GJ,. Cell and molecular biology of the exosome: how to make or break an RNA. Int Rev Cytol 2006; 251: 159-208.